Cargando…

Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial

IMPORTANCE: Close remote monitoring of patients following discharge for heart failure (HF) may reduce readmissions or death. OBJECTIVE: To determine whether remote monitoring of diuretic adherence and weight changes with financial incentives reduces hospital readmissions or death following discharge...

Descripción completa

Detalles Bibliográficos
Autores principales: Asch, David A., Troxel, Andrea B., Goldberg, Lee R., Tanna, Monique S., Mehta, Shivan J., Norton, Laurie A., Zhu, Jingsan, Iannotte, Lauren G., Klaiman, Tamar, Lin, Yuqing, Russell, Louise B., Volpp, Kevin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171555/
https://www.ncbi.nlm.nih.gov/pubmed/35532915
http://dx.doi.org/10.1001/jamainternmed.2022.1383
_version_ 1784721693190651904
author Asch, David A.
Troxel, Andrea B.
Goldberg, Lee R.
Tanna, Monique S.
Mehta, Shivan J.
Norton, Laurie A.
Zhu, Jingsan
Iannotte, Lauren G.
Klaiman, Tamar
Lin, Yuqing
Russell, Louise B.
Volpp, Kevin G.
author_facet Asch, David A.
Troxel, Andrea B.
Goldberg, Lee R.
Tanna, Monique S.
Mehta, Shivan J.
Norton, Laurie A.
Zhu, Jingsan
Iannotte, Lauren G.
Klaiman, Tamar
Lin, Yuqing
Russell, Louise B.
Volpp, Kevin G.
author_sort Asch, David A.
collection PubMed
description IMPORTANCE: Close remote monitoring of patients following discharge for heart failure (HF) may reduce readmissions or death. OBJECTIVE: To determine whether remote monitoring of diuretic adherence and weight changes with financial incentives reduces hospital readmissions or death following discharge with HF. DESIGN, SETTING, AND PARTICIPANTS: The Electronic Monitoring of Patients Offers Ways to Enhance Recovery (EMPOWER) study, a 3-hospital pragmatic trial, randomized 552 adults recently discharged with HF to usual care (n = 280) or a compound intervention (n = 272) designed to inform clinicians of diuretic adherence and changes in patient weight. Patients were recruited from May 25, 2016, to April 8, 2019, and followed up for 12 months. Investigators were blinded to assignment but patients were not. Analysis was by intent to treat. INTERVENTIONS: Participants randomized to the intervention arm received digital scales, electronic pill bottles for diuretic medication, and regret lottery incentives conditional on the previous day’s adherence to both medication and weight measurement, with $1.40 expected daily value. Participants’ physicians were alerted if participants’ weights increased 1.4 kg in 24 hours or 2.3 kg in 72 hours or if diuretic medications were missed for 5 days. Alerts and weights were integrated into the electronic health record. Participants randomized to the control arm received usual care and no further study contact. MAIN OUTCOMES AND MEASURES: Time to death or readmission for any cause within 12 months. RESULTS: Of the 552 participants, 290 were men (52.5%); 291 patients (52.7%) were Black, 231 were White (41.8%), and 16 were Hispanic (2.9%); mean (SD) age was 64.5 (11.8) years. The mean (SD) ejection fraction was 43% (18.1%). Each month, approximately 75% of participants were 80% adherent to both medication and weight measurement. There were 423 readmissions and 26 deaths in the control group and 377 readmissions and 23 deaths in the intervention group. There was no significant difference between the 2 groups for the combined outcome of all-cause inpatient readmission or death (unadjusted hazard ratio, 0.91; 95% CI, 0.74-1.13; P = .40) and no significant differences in all-cause inpatient readmission or observation stay or death, all-cause cardiovascular readmission or death, time to first event, and total all-cause deaths. Participants in the intervention group were slightly more likely to spend fewer days in the hospital. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, there was no reduction in the combined outcome of readmission or mortality in a year-long intensive remote monitoring program with incentives for patients previously hospitalized for HF. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02708654
format Online
Article
Text
id pubmed-9171555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-91715552022-06-16 Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial Asch, David A. Troxel, Andrea B. Goldberg, Lee R. Tanna, Monique S. Mehta, Shivan J. Norton, Laurie A. Zhu, Jingsan Iannotte, Lauren G. Klaiman, Tamar Lin, Yuqing Russell, Louise B. Volpp, Kevin G. JAMA Intern Med Original Investigation IMPORTANCE: Close remote monitoring of patients following discharge for heart failure (HF) may reduce readmissions or death. OBJECTIVE: To determine whether remote monitoring of diuretic adherence and weight changes with financial incentives reduces hospital readmissions or death following discharge with HF. DESIGN, SETTING, AND PARTICIPANTS: The Electronic Monitoring of Patients Offers Ways to Enhance Recovery (EMPOWER) study, a 3-hospital pragmatic trial, randomized 552 adults recently discharged with HF to usual care (n = 280) or a compound intervention (n = 272) designed to inform clinicians of diuretic adherence and changes in patient weight. Patients were recruited from May 25, 2016, to April 8, 2019, and followed up for 12 months. Investigators were blinded to assignment but patients were not. Analysis was by intent to treat. INTERVENTIONS: Participants randomized to the intervention arm received digital scales, electronic pill bottles for diuretic medication, and regret lottery incentives conditional on the previous day’s adherence to both medication and weight measurement, with $1.40 expected daily value. Participants’ physicians were alerted if participants’ weights increased 1.4 kg in 24 hours or 2.3 kg in 72 hours or if diuretic medications were missed for 5 days. Alerts and weights were integrated into the electronic health record. Participants randomized to the control arm received usual care and no further study contact. MAIN OUTCOMES AND MEASURES: Time to death or readmission for any cause within 12 months. RESULTS: Of the 552 participants, 290 were men (52.5%); 291 patients (52.7%) were Black, 231 were White (41.8%), and 16 were Hispanic (2.9%); mean (SD) age was 64.5 (11.8) years. The mean (SD) ejection fraction was 43% (18.1%). Each month, approximately 75% of participants were 80% adherent to both medication and weight measurement. There were 423 readmissions and 26 deaths in the control group and 377 readmissions and 23 deaths in the intervention group. There was no significant difference between the 2 groups for the combined outcome of all-cause inpatient readmission or death (unadjusted hazard ratio, 0.91; 95% CI, 0.74-1.13; P = .40) and no significant differences in all-cause inpatient readmission or observation stay or death, all-cause cardiovascular readmission or death, time to first event, and total all-cause deaths. Participants in the intervention group were slightly more likely to spend fewer days in the hospital. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, there was no reduction in the combined outcome of readmission or mortality in a year-long intensive remote monitoring program with incentives for patients previously hospitalized for HF. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02708654 American Medical Association 2022-05-09 2022-06 /pmc/articles/PMC9171555/ /pubmed/35532915 http://dx.doi.org/10.1001/jamainternmed.2022.1383 Text en Copyright 2022 Asch DA et al. JAMA Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Asch, David A.
Troxel, Andrea B.
Goldberg, Lee R.
Tanna, Monique S.
Mehta, Shivan J.
Norton, Laurie A.
Zhu, Jingsan
Iannotte, Lauren G.
Klaiman, Tamar
Lin, Yuqing
Russell, Louise B.
Volpp, Kevin G.
Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title_full Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title_fullStr Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title_full_unstemmed Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title_short Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial
title_sort remote monitoring and behavioral economics in managing heart failure in patients discharged from the hospital: a randomized clinical trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171555/
https://www.ncbi.nlm.nih.gov/pubmed/35532915
http://dx.doi.org/10.1001/jamainternmed.2022.1383
work_keys_str_mv AT aschdavida remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT troxelandreab remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT goldbergleer remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT tannamoniques remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT mehtashivanj remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT nortonlauriea remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT zhujingsan remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT iannottelaureng remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT klaimantamar remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT linyuqing remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT russelllouiseb remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial
AT volppkeving remotemonitoringandbehavioraleconomicsinmanagingheartfailureinpatientsdischargedfromthehospitalarandomizedclinicaltrial